[ad_1]
Fatal links between a type of diabetes drug and a life-threatening flesh-eating infection have been raised in a new report by the US Food and Drug Administration.
The study, published in the Annals of Internal Medicine, revealed links between a genital infection called Fournier's gangrene and a class of prescription drugs used for people with type 2 diabetes called glucose-cotransporter sodium inhibitors. -2.
The FDA has identified 55 cases of FG in patients who received SGLT2 inhibitors between March 2013 and January 2019, aged 22 to 87 years.
In 2017, approximately 1.7 million people received a prescription for the diabetes drug in retail pharmacies.
Of all patients surveyed in the study:
* All had damaged tissue that was removed surgically
* Eight had fecal bypass surgery
* Two amputations required because of flesh-eating bacteria
* Three deaths
According to the FDA, SGLT2 inhibitors are FDA-approved for use with diet and exercise to reduce blood sugar levels in adults with type 2 diabetes.
Last year, the FDA issued a warning linking the extremely rare and potentially fatal bacterial infection and SGLT2 inhibitors, which indicated that between March 2013 and May 2018, 12 cases of Infection have been discovered.
The 12 cases required hospitalization and surgery. One led to death.
With the increase in the number of cases, the FDA claims that FG is still a newly identified safety issue in patients receiving SGLT2 inhibitors.
The study warns that doctors prescribing the drug should be extremely aware of the possible complication of treatment and maintain a "high index of suspicion to recognize it in its infancy."
This story was brought back from Los Angeles
[ad_2]
Source link